Lumi-Cell Endocrine Disruptor Test Validation Supported By ICCVAM

Validation of the stably transfected recombinant cell based estrogen receptor transcription method should be designated a high priority to assess its usefulness as an in vitro assay to detect substances with in vitro ER agonist and or ER antagonist activity, the Interagency Coordinating Committee on the Validation of Alternative Methods recommended